Here's which one fits
It belongs to the class of growth hormone-releasing hormones (GHRH) and acts by stimulating the pituitary gland to produce more growth hormone, which can have various positive effects, including lean muscle mass growth, fat metabolism, and overall anti-aging benefits
Additionally, GLP-1 RAs with established CV benefitsspecifically liraglutide, subcutaneous semaglutide, dulaglutide, and efpeglenatideare recommended for patients with T2DM and ASCVD to reduce CV events, regardless of baseline or target HbA1c levels or concurrent glucose-lowering therapy (Class I, LoE A)
GLP-1 therapies address one of them particularly well
Technical prevention of deletion and manipulation, backed by validated backup/archival and periodic verification of restore capability